
| ASSET | DATE | % RETURN |
|---|---|---|
NLS Pharmaceutics (NLSPW) | 8/28/2022 - 9/14/2022 | 195.15% |
RDE (GIFT) | 8/28/2022 - 9/14/2022 | 182.89% |
Akero Therapeutics (AKRO) | 8/28/2022 - 9/14/2022 | 132.58% |
Diversified Energy (DEC) | 8/28/2022 - 9/14/2022 | 109.37% |
Immuneering (IMRX) | 8/28/2022 - 9/14/2022 | 108.12% |
NewcelX (NCEL) | 8/28/2022 - 9/14/2022 | 108% |
Sunrise New Energy (EPOW) | 8/28/2022 - 9/14/2022 | 92.86% |
Enliven Therapeutics (ELVN) | 8/28/2022 - 9/14/2022 | 86.44% |
Ventyx Biosciences (VTYX) | 8/28/2022 - 9/14/2022 | 84.2% |
Annovis Bio (ANVS) | 8/28/2022 - 9/14/2022 | 84.2% |
InMed Pharmaceuticals (INM) | 8/28/2022 - 9/14/2022 | 70.28% |
Venus Concept (VERO) | 8/28/2022 - 9/14/2022 | 63.19% |
Immunitybio (IBRX) | 8/28/2022 - 9/14/2022 | 61.87% |
Huadi International (HUDI) | 8/28/2022 - 9/14/2022 | 56.81% |
Arqit Quantum Inc Warrants (ARQQW) | 8/28/2022 - 9/14/2022 | 56.25% |
CareCloud (CCLD) | 8/28/2022 - 9/14/2022 | 56.19% |
Shuttle Pharmaceuticals (SHPH) | 8/28/2022 - 9/14/2022 | 55.93% |
Bausch Health Companies (BHC) | 8/28/2022 - 9/14/2022 | 55.14% |
Jowell Global (JWEL) | 8/28/2022 - 9/14/2022 | 54.62% |
Hyperion DeFi (HYPD) | 8/28/2022 - 9/14/2022 | 54.09% |
Belite Bio Inc ADR (BLTE) | 8/28/2022 - 9/14/2022 | 48.32% |
New York City REIT (NYC) | 8/28/2022 - 9/14/2022 | 46.18% |
Fubotv (FUBO) | 8/28/2022 - 9/14/2022 | 44.63% |
OKYO Pharma Ltd ADR (OKYO) | 8/28/2022 - 9/14/2022 | 44.5% |
Arqit Quantum (ARQQ) | 8/28/2022 - 9/14/2022 | 44.36% |